These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 12618217)
21. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB. Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512 [TBL] [Abstract][Full Text] [Related]
22. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. Thornburg NJ; Raab-Traub N J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446 [TBL] [Abstract][Full Text] [Related]
23. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703 [TBL] [Abstract][Full Text] [Related]
24. The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7. Wang L; Wang Y; Zhao J; Ren J; Hall KH; Moorman JP; Yao ZQ; Ning S J Virol; 2017 Feb; 91(4):. PubMed ID: 27903798 [TBL] [Abstract][Full Text] [Related]
25. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034 [TBL] [Abstract][Full Text] [Related]
27. Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. Tang W; Pavlish OA; Spiegelman VS; Parkhitko AA; Fuchs SY J Biol Chem; 2003 Dec; 278(49):48942-9. PubMed ID: 14523018 [TBL] [Abstract][Full Text] [Related]
28. The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines. Kim JE; Jun S; Song M; Kim JH; Song YJ Food Chem Toxicol; 2012 May; 50(5):1524-8. PubMed ID: 22387267 [TBL] [Abstract][Full Text] [Related]
29. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation. Zuercher E; Butticaz C; Wyniger J; Martinez R; Battegay M; Boffi El Amari E; Dang T; Egger JF; Fehr J; Mueller-Garamvögyi E; Parini A; Schaefer SC; Schoeni-Affolter F; Thurnheer C; Tinguely M; Telenti A; Rothenberger S; PLoS One; 2012; 7(2):e32168. PubMed ID: 22384168 [TBL] [Abstract][Full Text] [Related]
30. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression. Johansson P; Jansson A; Rüetschi U; Rymo L J Virol; 2009 Feb; 83(3):1393-401. PubMed ID: 19019967 [TBL] [Abstract][Full Text] [Related]
34. Unique signaling properties of CTAR1 in LMP1-mediated transformation. Mainou BA; Everly DN; Raab-Traub N J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074 [TBL] [Abstract][Full Text] [Related]
35. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Cahir McFarland ED; Izumi KM; Mosialos G Oncogene; 1999 Nov; 18(49):6959-64. PubMed ID: 10602470 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation. Floettmann JE; Rowe M Oncogene; 1997 Oct; 15(15):1851-8. PubMed ID: 9362452 [TBL] [Abstract][Full Text] [Related]
37. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139 [TBL] [Abstract][Full Text] [Related]
38. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482 [TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. Najjar I; Baran-Marszak F; Le Clorennec C; Laguillier C; Schischmanoff O; Youlyouz-Marfak I; Schlee M; Bornkamm GW; Raphaël M; Feuillard J; Fagard R J Virol; 2005 Apr; 79(8):4936-43. PubMed ID: 15795279 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]